CN105998797B - 以金花茶-石斛为原料的解酒颗粒剂及其生产方法 - Google Patents
以金花茶-石斛为原料的解酒颗粒剂及其生产方法 Download PDFInfo
- Publication number
- CN105998797B CN105998797B CN201610456013.9A CN201610456013A CN105998797B CN 105998797 B CN105998797 B CN 105998797B CN 201610456013 A CN201610456013 A CN 201610456013A CN 105998797 B CN105998797 B CN 105998797B
- Authority
- CN
- China
- Prior art keywords
- parts
- camellia
- weight
- dendrobium
- granule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000008187 granular material Substances 0.000 title claims abstract description 36
- 241001657422 Camellia petelotii Species 0.000 title claims abstract description 14
- 206010019133 Hangover Diseases 0.000 title claims description 9
- 238000002360 preparation method Methods 0.000 title description 2
- 235000018597 common camellia Nutrition 0.000 claims abstract description 29
- 240000001548 Camellia japonica Species 0.000 claims abstract description 28
- 241001076416 Dendrobium tosaense Species 0.000 claims abstract description 19
- 239000000463 material Substances 0.000 claims abstract description 19
- 240000001432 Calendula officinalis Species 0.000 claims abstract description 18
- 241001598107 Imperata Species 0.000 claims abstract description 18
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 17
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 claims abstract description 16
- 235000003880 Calendula Nutrition 0.000 claims abstract description 16
- 244000025254 Cannabis sativa Species 0.000 claims abstract description 12
- 238000004519 manufacturing process Methods 0.000 claims abstract description 12
- 239000011858 nanopowder Substances 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 239000004480 active ingredient Substances 0.000 claims abstract description 5
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract description 4
- 241000219780 Pueraria Species 0.000 claims abstract description 4
- 244000046146 Pueraria lobata Species 0.000 claims description 15
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 15
- 229920001202 Inulin Polymers 0.000 claims description 13
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 13
- 229940029339 inulin Drugs 0.000 claims description 13
- 238000003756 stirring Methods 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 229920001542 oligosaccharide Polymers 0.000 claims description 5
- 150000002482 oligosaccharides Chemical class 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 4
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 4
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 4
- 241000209507 Camellia Species 0.000 claims description 3
- 244000269722 Thea sinensis Species 0.000 claims description 3
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 claims description 3
- 235000006468 Thea sinensis Nutrition 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 51
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 37
- 210000002784 stomach Anatomy 0.000 abstract description 22
- 210000004369 blood Anatomy 0.000 abstract description 20
- 239000008280 blood Substances 0.000 abstract description 20
- 210000004185 liver Anatomy 0.000 abstract description 19
- 230000001737 promoting effect Effects 0.000 abstract description 17
- 230000002075 anti-alcohol Effects 0.000 abstract description 12
- 206010028980 Neoplasm Diseases 0.000 abstract description 11
- 230000002496 gastric effect Effects 0.000 abstract description 10
- 230000036772 blood pressure Effects 0.000 abstract description 8
- 230000032683 aging Effects 0.000 abstract description 7
- 150000004676 glycans Chemical class 0.000 abstract description 7
- 230000036541 health Effects 0.000 abstract description 7
- 229920001282 polysaccharide Polymers 0.000 abstract description 7
- 239000005017 polysaccharide Substances 0.000 abstract description 7
- 239000011669 selenium Substances 0.000 abstract description 7
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract description 6
- 150000001413 amino acids Chemical class 0.000 abstract description 6
- 230000036039 immunity Effects 0.000 abstract description 6
- 230000002633 protecting effect Effects 0.000 abstract description 6
- 229910052711 selenium Inorganic materials 0.000 abstract description 6
- 235000011649 selenium Nutrition 0.000 abstract description 6
- 231100000331 toxic Toxicity 0.000 abstract description 6
- 230000002588 toxic effect Effects 0.000 abstract description 6
- 229930003944 flavone Natural products 0.000 abstract description 5
- 235000011949 flavones Nutrition 0.000 abstract description 5
- 210000004877 mucosa Anatomy 0.000 abstract description 5
- 239000011573 trace mineral Substances 0.000 abstract description 5
- 235000013619 trace mineral Nutrition 0.000 abstract description 5
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 abstract description 4
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 210000004556 brain Anatomy 0.000 abstract description 4
- 150000002212 flavone derivatives Chemical class 0.000 abstract description 4
- 210000003734 kidney Anatomy 0.000 abstract description 4
- 230000003859 lipid peroxidation Effects 0.000 abstract description 4
- 229930003231 vitamin Natural products 0.000 abstract description 4
- 235000013343 vitamin Nutrition 0.000 abstract description 4
- 239000011782 vitamin Substances 0.000 abstract description 4
- 229940088594 vitamin Drugs 0.000 abstract description 4
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 abstract description 4
- 238000001784 detoxification Methods 0.000 abstract description 3
- 238000001727 in vivo Methods 0.000 abstract description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 abstract description 3
- 229930182490 saponin Natural products 0.000 abstract description 3
- 150000007949 saponins Chemical class 0.000 abstract description 3
- RYAHJFGVOCZDEI-UFFNCVEVSA-N Dendrobine Chemical compound C([C@H]1CC[C@@H]2[C@@]31C)N(C)[C@@H]3[C@H]1[C@@H](C(C)C)[C@@H]2C(=O)O1 RYAHJFGVOCZDEI-UFFNCVEVSA-N 0.000 abstract description 2
- 108010064851 Plant Proteins Proteins 0.000 abstract description 2
- 230000008827 biological function Effects 0.000 abstract description 2
- RYAHJFGVOCZDEI-CZKZLRAZSA-N dendrobine Natural products O=C1O[C@@H]2[C@H](C(C)C)[C@H]1[C@H]1[C@@]3(C)[C@@H]2N(C)C[C@H]3CC1 RYAHJFGVOCZDEI-CZKZLRAZSA-N 0.000 abstract description 2
- 210000002249 digestive system Anatomy 0.000 abstract description 2
- 230000029142 excretion Effects 0.000 abstract description 2
- 235000021118 plant-derived protein Nutrition 0.000 abstract description 2
- 230000002936 tranquilizing effect Effects 0.000 abstract description 2
- 210000000232 gallbladder Anatomy 0.000 abstract 1
- 230000006870 function Effects 0.000 description 17
- 230000035622 drinking Effects 0.000 description 16
- 239000003814 drug Substances 0.000 description 16
- 241000723353 Chrysanthemum Species 0.000 description 14
- 208000007848 Alcoholism Diseases 0.000 description 13
- 208000024891 symptom Diseases 0.000 description 13
- 201000007930 alcohol dependence Diseases 0.000 description 12
- 241001122767 Theaceae Species 0.000 description 11
- 238000000034 method Methods 0.000 description 8
- 206010037660 Pyrexia Diseases 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 230000035922 thirst Effects 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 241001523681 Dendrobium Species 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 210000000936 intestine Anatomy 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 235000014101 wine Nutrition 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 240000004638 Dendrobium nobile Species 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 3
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 208000007882 Gastritis Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 210000001156 gastric mucosa Anatomy 0.000 description 3
- 229910052732 germanium Inorganic materials 0.000 description 3
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000000171 quenching effect Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 208000018556 stomach disease Diseases 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 235000005881 Calendula officinalis Nutrition 0.000 description 2
- MKMCJLMBVKHUMS-UHFFFAOYSA-N Coixol Chemical compound COC1=CC=C2NC(=O)OC2=C1 MKMCJLMBVKHUMS-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 241000208812 Flaveria bidentis Species 0.000 description 2
- 102100021022 Gastrin Human genes 0.000 description 2
- 108010052343 Gastrins Proteins 0.000 description 2
- 241000590002 Helicobacter pylori Species 0.000 description 2
- 206010019668 Hepatic fibrosis Diseases 0.000 description 2
- 206010020710 Hyperphagia Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- 206010067125 Liver injury Diseases 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- 208000019229 Spleen disease Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 206010000059 abdominal discomfort Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 2
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 229940037467 helicobacter pylori Drugs 0.000 description 2
- 231100000753 hepatic injury Toxicity 0.000 description 2
- 230000010224 hepatic metabolism Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000003914 insulin secretion Effects 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000020830 overeating Nutrition 0.000 description 2
- 125000001792 phenanthrenyl group Chemical class C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 208000027140 splenic disease Diseases 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 230000004614 tumor growth Effects 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 210000004916 vomit Anatomy 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- IECBDTGWSQNQID-JGVFFNPUSA-N (1r,5s)-4,6,6-trimethylbicyclo[3.1.1]hept-3-en-7-one Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2=O IECBDTGWSQNQID-JGVFFNPUSA-N 0.000 description 1
- PDZWMZKEQIIYKL-HQVZTVAUSA-N (2s)-2-[[4-[1-(2,4-diaminopteridin-6-yl)ethyl-methylamino]benzoyl]amino]pentanedioic acid Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1C(C)N(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 PDZWMZKEQIIYKL-HQVZTVAUSA-N 0.000 description 1
- ABTRFGSPYXCGMR-KXQOOQHDSA-N (3R)-beta,psi-caroten-3-ol Chemical compound CC(C)=CCCC(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C ABTRFGSPYXCGMR-KXQOOQHDSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 206010002482 Angiosclerosis Diseases 0.000 description 1
- KMOUJOKENFFTPU-UHFFFAOYSA-N Apigenin-7-glucosid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C=C(C=3C=CC(O)=CC=3)OC2=C1 KMOUJOKENFFTPU-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- MRNPHCMRIQYRFU-KXUMSINMSA-N Arundoin Chemical compound C([C@]1(C)[C@@H](C(C)C)CC[C@H]1[C@]1(C)CC=C23)C[C@]1(C)[C@H]3CC[C@@H]1[C@]2(C)CC[C@H](OC)C1(C)C MRNPHCMRIQYRFU-KXUMSINMSA-N 0.000 description 1
- NWUMSRKLBRWRAS-UHFFFAOYSA-N Arundoin Natural products COC1CCC2(C)C(CCC3C2=CCC4(C)C5CC(C)(C)CCC5(C)CCC34C)C1(C)C NWUMSRKLBRWRAS-UHFFFAOYSA-N 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 208000004300 Atrophic Gastritis Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241001328788 Camellia nitidissima Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 description 1
- IECBDTGWSQNQID-UHFFFAOYSA-N Chrysanthenon Natural products CC1=CCC2C(C)(C)C1C2=O IECBDTGWSQNQID-UHFFFAOYSA-N 0.000 description 1
- IECBDTGWSQNQID-SFYZADRCSA-N Chrysanthenone Natural products CC1=CC[C@H]2C(C)(C)[C@@H]1C2=O IECBDTGWSQNQID-SFYZADRCSA-N 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- ACBOFPQSBWBAQR-UHFFFAOYSA-N Cosmosiin Natural products OCC1OC(Oc2cc(O)c3C(=O)C=C(Oc3c2)c4cccc(O)c4)C(O)C(O)C1O ACBOFPQSBWBAQR-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 241000026010 Dendrobium candidum Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 210000000712 G cell Anatomy 0.000 description 1
- 208000036495 Gastritis atrophic Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 208000019926 Keshan disease Diseases 0.000 description 1
- CMUNUTVVOOHQPW-LURJTMIESA-N L-proline betaine Chemical compound C[N+]1(C)CCC[C@H]1C([O-])=O CMUNUTVVOOHQPW-LURJTMIESA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000025174 PANDAS Diseases 0.000 description 1
- 208000021155 Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000000220 Panda oleosa Species 0.000 description 1
- 235000016496 Panda oleosa Nutrition 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 241001646828 Platostoma chinense Species 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- PEFASEPMJYRQBW-HKWQTAEVSA-N Robinin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)C=C3OC=2C=2C=CC(O)=CC=2)=O)O1 PEFASEPMJYRQBW-HKWQTAEVSA-N 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000046109 Sorghum vulgare var. nervosum Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 239000002115 aflatoxin B1 Substances 0.000 description 1
- OQIQSTLJSLGHID-WNWIJWBNSA-N aflatoxin B1 Chemical compound C=1([C@@H]2C=CO[C@@H]2OC=1C=C(C1=2)OC)C=2OC(=O)C2=C1CCC2=O OQIQSTLJSLGHID-WNWIJWBNSA-N 0.000 description 1
- 229930020125 aflatoxin-B1 Natural products 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- KMOUJOKENFFTPU-QNDFHXLGSA-N apigenin 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C=C(C=3C=CC(O)=CC=3)OC2=C1 KMOUJOKENFFTPU-QNDFHXLGSA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 235000021167 banquet Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 201000006824 bubonic plague Diseases 0.000 description 1
- 239000004566 building material Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000009084 cardiovascular function Effects 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 210000003989 endothelium vascular Anatomy 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 1
- DDELFAUOHDSZJL-UHFFFAOYSA-N kaempferol 3-O-rutinoside-7-O-rhamnoside Natural products OC1C(O)C(O)C(C)OC1OC1C(O)C(O)C(CO)OC1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C1=O DDELFAUOHDSZJL-UHFFFAOYSA-N 0.000 description 1
- PEFASEPMJYRQBW-UHFFFAOYSA-N kaempferol 7-O-alpha-L-rhamnopyradoside 3-O-beta-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(OC4C(C(O)C(O)C(C)O4)O)C=C3OC=2C=2C=CC(O)=CC=2)=O)O1 PEFASEPMJYRQBW-UHFFFAOYSA-N 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007056 liver toxicity Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- XSYCDVWYEVUDKQ-UHFFFAOYSA-N meso-Calycanthin Natural products N1C2=CC=CC=C2C23CCN(C)C1C21C2=CC=CC=C2NC3N(C)CC1 XSYCDVWYEVUDKQ-UHFFFAOYSA-N 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- PEFASEPMJYRQBW-XMWKPCQISA-N robinin Natural products O(C[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](OC2=C(c3ccc(O)cc3)Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@@H](O)[C@@H](C)O4)c3)C2=O)O1)[C@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 PEFASEPMJYRQBW-XMWKPCQISA-N 0.000 description 1
- 239000000455 rubixanthin Substances 0.000 description 1
- ABTRFGSPYXCGMR-SDPRXREBSA-N rubixanthin Natural products O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=C(\CC/C=C(\C)/C)/C)\C)/C)\C)/C)=C(C)C1 ABTRFGSPYXCGMR-SDPRXREBSA-N 0.000 description 1
- 235000009514 rubixanthin Nutrition 0.000 description 1
- 244000209700 shan ge teng Species 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- CMUNUTVVOOHQPW-ZCFIWIBFSA-N stachydrine Natural products C[N+]1(C)CCC[C@@H]1C([O-])=O CMUNUTVVOOHQPW-ZCFIWIBFSA-N 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 229960004559 theobromine Drugs 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
- 235000020097 white wine Nutrition 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了以金花茶‑石斛为原料的解酒颗粒剂及其生产方法,这种颗粒剂有效成分的原料的重量份如下:金花茶叶或茶花15‑25份,葛根叶或花20‑40份,金盏花15‑20份,铁皮石斛纳米粉1‑5份,白茅根10‑20份,菊花15‑30份。本发明的解酒颗粒剂含有金花茶皂甙、金花茶黄酮、石斛多糖、石斛碱、多种氨基酸、微量元素硒、植物蛋白、维生素等成分,可消酒、清热解毒、镇静、清肺清脑、护肝护胆护胃的功效。其有效成分会在体内迅速分解代谢酒精,促进肝脏解毒、肾脏排泄的功能,还可起到恢复肠胃粘膜和正常菌群,促进消化系统健康,同时具有活血化瘀、降低血糖血压血脂提高免疫能力、抗脂质过氧化、抗肿瘤、抗衰老等生物功能。
Description
技术领域
本发明涉及解酒保健品技术领域,具体是一种以金花茶-石斛为原料具有解酒功能的保健颗粒剂及其生产方法。
背景技术
中国是酒文化王国。自古以来,举凡年节吉日、婚丧嫁娶、庆生奠死、宴亲飨客、洗尘饯行等等,人们生活的方方面面、时时刻刻几乎都离不开酒。饮酒,也是如今人们日常生活的一项重要内容,随着我国市场经济的发展,商业活动日趋频繁,人们在日常应酬中免不了时常饮酒,由于大量饮酒造成的身体不适状况屡见不鲜,饮酒者的身体健康受到威胁。
酒精在体内的代谢过程,主要在肝脏中进行,少量酒精可在进入人体之后,马上随肺部呼吸或经汗腺排出体外,绝大部分酒精在肝脏中先与乙醇脱氢酶作用,生成乙醛,乙醛对人体有害,但它很快会在乙醛脱氢酶的作用下转化成乙酸。乙酸是酒精进入人体后产生的唯一有营养价值的物质,它可以提供人体需要的热量。酒精在人体内的代谢速率是有限度的,如果饮酒过量,酒精就会在体内器官,特别是在肝脏和大脑中积蓄,积蓄至一定程度即出现酒精中毒症状。
酒精的化学成分是乙醇,人们饮酒后,乙醇首先在胃内储留,与胃十二指肠黏膜直接接触。正常的胃黏膜表层上皮细胞和胃小凹清晰可见,分布很均匀,酒精能导致黏液变薄,粘膜上皮细胞坏死脱落,微血管内皮损伤、栓塞,组织缺血血氧坏死,从而引起胃黏膜糜烂或溃疡形成。近年来随着生活水平的提高,饮酒的相对增多,酒精刺激引起的胃炎亦有所增加。
对于醉酒人们的传统做法是喝醋或者喝茶,但效果甚微,主要原因是茶叶中的咖啡碱,茶碱,可可碱等有兴奋心脏的作用,饮酒后喝茶会增加对心脏的刺激,喝醋不但不能解酒,而且对消化道黏膜还会产生损伤。临床上通常使用各类口服西药,虽然药效明显但会对患者产生一些副作用。
金花茶是一种古老的植物,极为罕见,分布极其狭窄,全世界90%的野生金花茶仅分布于中国广西壮族自治区防城港市十万大山的兰山支脉一带,生长于海拔700米以下,数量极少,是世界上稀有的珍贵植物。经检验表明,金花茶属无毒级、含有400多种营养物质、无毒副作用。富含茶多糖、茶多酚、总皂甙、总黄酮、茶色素、咖啡因、蛋白质、维生素B1、B2、维生素C、维生素E、叶酸、脂肪酸、B-胡萝卜素等多种天然营养成份;金花茶含有茶氨酸、苏氨酸等几十种氨基酸,以及富含有多种对人体具有重要保健作用的天然有机锗(Ge)、硒(Se)、钼(M)、锌(Zn)、钒(V)等微量元素,和钾(K)、钙(Ca)、镁(Mg)等宏量元素。民间又称金花茶为“神茶”,国外称之为神奇的东方魔茶,被誉为“植物界大熊猫”、“茶族皇后”。金花茶具有明显的降血糖和尿糖作用,能有效的改善糖尿病“三高”症状。金花茶在有效降低血糖、血压的同时,可有效降低血脂,改善因高血压而引起的各种不适应症状,降低血清中胆固醇和B-脂蛋白,促进胰岛素分泌、增强免疫力、调节血流量,防止动脉粥样硬化,抗菌消炎、清热解毒、通便利尿去湿,增进肝脏代谢、防癌抑制肿瘤生长等。此外,我们的研究表明,金花茶对于提高体内的乙醛脱氢酶具有显著的作用,因此将金花茶和其他具有提高乙醇脱氢酶活性的原料搭配,可以起到加快酒精分解,缓解酒后中毒症状的作用。
目前市场上的解酒颗粒剂含化学成分的居多,有一定的副作用,功效单一不明显,大部分只能在当时缓解酒醉的症状,对于酒精造成的肠胃损伤及肠道菌群失调而导致的副作用并没有起到很好的恢复作用。本发明利用金花茶特有的药用价值,结合石斛等辅料,制成一种风味独特、解酒功效强,酒后肠胃恢复快,且具有清脑提神、清凉降火、生津解渴、减脂降压、健胃消食等保健作用的解酒颗粒剂。
发明内容
本发明的目的是利用金花茶和石斛特有的功能,加入一些常见的能够食用的植物叶或花,结合解酒中药的效力,克服了传统解酒颗粒剂酒后机体恢复效果不佳、副作用明显的缺陷,具有清脑提神、清凉降火、生津解渴、减脂降压、健胃消食的作用。
本发明是通过以下技术方案实现的:
以金花茶-石斛为原料的解酒颗粒剂由有效成分和辅料制成,所述有效成分的原料的重量份如下:金花茶叶或茶花15-25份,葛根叶或花20-40份,金盏花15-20份,铁皮石斛纳米粉1-5份,白茅根10-20份,菊花15-30份。
以上所述的辅料为菊粉和低聚糖类,加入的总重量份数为5-10;所述低聚糖类包括低聚果糖、低聚木糖、低聚麦芽糖的一种或几种。
包括以下工艺步骤:将金花茶或茶花、葛根叶或花、金盏花、白茅根和菊花按重量份比配好后,送入粉碎机粉碎,搅拌均匀,再加入其重量8-10倍的水,煎煮两次后过滤,将滤液浓缩成60℃时相对密度1.2-1.4的稠膏,加入铁皮石斛纳米粉和辅料,快速搅拌干燥制粒,按每包4-6g包装、检验、装袋、装箱,颗粒剂制成。
本解酒颗粒剂各组分在传统中医学理论中的作用如下:
金花茶(拉丁学名:Camellia nitidissima C. W. Chi):金花茶在有效降低血糖、血压的同时,可有效降低血脂,改善因高血压而引起的各种不适应症状,降低血清中胆固醇和B-脂蛋白,促进胰岛素分泌、增强免疫力、调节血流量,防止动脉粥样硬化,抗菌消炎、清热解毒、通便利尿去湿,增进肝脏代谢、防癌抑制肿瘤生长等。金花茶中的总黄酮含量4400mg/kg, 黄酮类化合物具有降血压、降血脂、防止血栓形成、防治心脑血管疾病、增强免疫、降低血管脆性、改善心脑血管血液循环等作用,还可以抗菌及抗病毒,抗氧化、抗衰老,抗辐射,止咳、祛痰,以及抗肝脏毒。硒是人体红细胞中谷胱甘肽酶的成份,他有抗氧化,保护细胞膜,保护心血管的作用。中国科学家还发现,硒是治疗克山病和大骨节病的有效药物,此外,硒还有解毒功能,降低黄曲B1的毒性,对某些化学致癌物质有减毒作用,还能减轻毒素对肝细胞的损害。锗可降低癌细胞的生物电位,改变其生理状态,抑制癌细胞的增值生长,还可诱发人体内抗癌物质的干扰素,能将巨噬细胞诱发变为抗癌细胞,故有人用锗治疗癌症,另外锗对血管硬化,脑血栓,脑出血,肾肝病,胃病,糖尿病,关节炎,慢性神经痛也有明显的疗效。金花茶花的作用,能够收敛止血,主便血;月经过多,对妇女特别有好处。
葛根(拉丁学名:Pueraria omeiensis Wang et Tang ):别名葛条,甘葛,葛藤,味甘微辛,气清香,性凉,主入脾胃经。有发表解肌,升阳透疹,解热生津之功效。用于治疗脾虚泄泻、热病口渴、主治外感发热,头项痛强,麻疹透发不畅,温病口渴,消渴,酒毒,胸痹心痛等病症。现代研究表明,葛根含有多种人体必须的氨基酸、维生素及黄酮等,具有治疗心脑血管疾病、预防动脉硬化、抗氧化、促进新陈代谢,加强肝脏解毒功能,防止酒精对肝脏的损伤;强化肝胆细胞自身免疫功能,抵抗病毒入侵。在本发明的组方中主要起以下作用:发表退热、生津止渴、解饮酒后口渴,解酒精、解鱼蟹毒;提高肝细胞的再生能力,恢复正常肝脏机能,促进胆汁分泌,防止脂肪在肝脏堆积,有效预防饮酒造成的酒精肝、脂肪肝等作用。
金盏花(拉丁学名:Calendula officinalis L):金盏花富含多种维生素,尤其是维生素A和维生素C,可预防色素沉淀、增进皮肤光泽与弹性、减缓衰老、避免肌肤松弛生皱。几乎各部位都可以食用;其花瓣有美容之功能,花含类胡萝卜素、番茄烃、蝴蝶梅黄素、玉红黄质、挥发油、树脂、黏液质、苹果酸等。根含苦味质,山金东二醇;种子含甘油酯、蜡醇和生物碱。主要药理作用有:有抗菌、消炎作用;降血脂作用,对肝脏总脂质、胆固醇和三酸甘油也有降低作用;金盏花中的多糖成分有较强的免疫刺激作用;金盏菊花提取物对中枢神经系统有镇静作用,可降低反射兴奋性;静脉注射可降低血压,增强心脏活动,增大心跳振幅,减慢心率;能促进胆汁分泌,加速创伤愈合。欧洲民间有内服金盏菊花治疗胃及十二指肠溃疡、胃炎、肝胆疾患等的习俗。若用于消化道癌肿可减轻中毒症状、改善食欲、睡眠等,亦有用于月经不调者。古埃及人认为金盏花能延缓衷老,印度人则尊奉它为神圣的花。中世纪时人们已将金盏花用于疗伤,更藉以对抗瘟疫和黑死病。
铁皮石斛(拉丁学名:Dendrobium officinale Kimura et Migo):石斛属多年生草本植物的新鲜或干燥茎。铁皮石斛又名铁皮枫斗、耳环石斛、铁皮兰、黑节草等,为石斛之上品,名列“中华九大仙草”之首。其味甘,性微寒, 归胃、肾经, 具有养阴清热、益胃生津的功效,药用价值历代为人们所推崇。铁皮石斛主要含石斛多糖、生物碱、氨基酸、微量元素和菲类化合物等有效成分,多糖成分可增强机体免疫机能、抗肿瘤、抗衰老、抗疲劳、降血糖。生物碱类成分的药理作用主要表现对心血管、胃肠道作用及退热止痛等。铁皮石斛中含有的菲类化合物均具有抗癌活性,可增强巨噬细胞的吞噬作用,能促进T细胞生长和淋巴细胞产生移动抑制因子,明显提升外周白细胞,起到增强免疫功能的作用。现代研究表明,铁皮石斛具有增强机体免疫力、抗肿瘤、促进消化液分泌、抑制血小板凝集、降血脂、降血糖、抗氧化、抗衰老和退热止痛等药理作用。铁皮石斛的养胃生津作用较强,历代医家称其“久服厚胃”,“平胃气,长肌肉”,“理胃气,清胃火”。因此,人们还将它称之为“肠胃药”,是治疗胃脘痛、上腹胀满的常用药物。能促进胃液的分泌,增强胃的排空能力,帮助消化,并能保护胃黏膜的损伤,明显改善功能性消化不良者症状。石斛还能使人血中的促胃液素浓度升高,而促胃液素是由分布在胃窦及小肠上部黏膜的G细胞分泌的,有益于慢性萎缩性胃炎的治疗。石斛对脾胃病中的致病菌—幽门螺杆菌有较好的抑制作用,有助于治疗萎缩性胃炎、浅表性胃炎等幽门螺杆菌阳性的病症,是脾胃病的理想药物。
白茅根(拉丁学名:Imperata cylindrica):别称丝茅草、茅草、白茅草,为禾本科植物多年生草本白茅的根茎。《神农本草经》曰:“茅根,味甘寒。主劳伤虚赢,补中益气,除瘀血血闭寒热,利小便。其苗,主下水。”《名医别录》曰:“茅根,无毒。主下五淋,除客热在肠胃,止渴,坚筋,妇人崩中。久服利人。”具有凉血止血,清热解毒之功效。现代药理学认为,它含淀粉和多量蔗糖、葡萄糖以及少量果糖、木糖、柠檬酸、草酸、苹果酸;其根茎还含甘露醇、薏苡素和芦竹素等成分。它所含丰富的钾盐有良好的利尿作用,煎液对某些痢疾杆菌有明显的抑菌作用。现代临床研究证实本品具有良好的止血、利尿、抗感染的作用,对病毒性肝炎疗效亦颇佳,众多医家都认为它清热利水而不伤肾。
菊花(拉丁学名:Dendranthema morifolium(Ramat. )Tzvel.):别称寿客、金英、黄华、秋菊、陶菊、日精、女华、延年、隐逸花,属菊目菊科多年生草本植物,主要成分为挥发油、黄酮类、三萜类及氨基酸、微量元素等,并富含挥发油、菊酮、龙脑、龙脑己酸酯及水苏碱、刺槐甙、木樨草甙、大波斯菊甙、腺膘呤、胆碱、葡萄糖甙等物质成分,具有养肝明目、散风清热、消咳止痛等多种药理活性,对于降低血压、预防高血脂、抗菌、抗病毒、抗炎、抗衰老、治疗冠心病、头痛眩晕、目赤肿痛、风热感冒、咳嗽等病症效果显著。汉朝《神农本草经》记载:“菊花久服能轻身延年”。菊花具有疏风、清热、明目、解毒之功效,并对葡萄球菌、链球菌及绿脓杆菌有抑制及杀灭作用。本发明可以采用黄菊或白菊。
菊粉(拉丁学名:Synanthrin):菊粉是植物中储备性多糖,在自然界中的分布十分广泛,某些真菌和细菌中也含有菊粉,但其主要来源是植物。菊粉是一种天然存在的膳食纤维,在人体内可延长碳水化合物的供能时间而又不显著提高血糖水平,代谢不需要胰岛素,有助于减少糖尿病人对胰岛素的依赖性和需要,控制血糖水平。对肠道双歧杆菌、乳酸杆菌的上涨还具有明显的促进作用。摄入一定量的菊粉能徐进矿物元素尤其是磷酸钙的吸收量,促进钙在骨骼中的吸收和沉淀,防治骨质疏松。另外菊粉还具有促进消化、排便和新陈代谢,去除湿疹、美肤、减肥、护肝、抗抑郁的功能,并且不提供能量,适合糖尿病人食用。
由于采用了上述技术方案,本发明与现有技术相比具有如下有益效果:
本发明的解酒颗粒剂中,金花茶、葛根、白茅根、菊花联合使用可以明显增强金花茶的解酒作用,同时提高肝脏乙醇脱氢酶 (alcoholdehydrogenase,ADH)和乙醛脱氢酶的活性,其解酒作用与增强乙醇的生物转化有关。发挥协同解酒作用,对急、慢性酒精中毒均能发挥一定的解酒作用。此外,还具有抗脂质过氧化作用,对肝损伤、肝纤维化以及肝硬化亦具有一定的防治作用。再加上白茅根的协同作用,使解酒作用增强,发挥健胃消食功能,以缓解饮酒过程中过食肥甘引起的肠胃负担;而葛根又能增强肠胃的上下开阖功能;菊花护肝明目,清热解毒,可解酒后虚火。
此外,君药均具有抗脂质过氧化作用,对肝损伤、肝纤维化以及肝硬化可有防治作用。再加上铁皮石斛可修复酒后胃肠粘膜的损伤;菊粉、低聚糖类可迅速恢复因饮酒导致的肠道菌群失调,重建健康的肠道微生物系统;白茅根使解酒作用增强,发挥健胃消食功能,以缓解饮酒过程中过食肥甘引起的肠胃负担;而葛根又能增强肠胃的上下开阖功能;菊花护肝明目,清热解毒,可解酒后虚火;菊粉的加入还延长了颗粒剂的保质期。
本发明的解酒颗粒剂含有金花茶皂甙、金花茶黄酮、石斛多糖、石斛碱、多种氨基酸、微量元素硒、植物蛋白、维生素等成分,具有缓解酒后发热烦渴,呕逆吐酸等症状,具有憎寒、壮热、解酒醒脾、酒痢、饮食不思、胸膈饱胀、发呃、呕吐酸痰、酒毒伤胃、消热、清肺等功效。其有效成分会在体内激活酒精代谢通路的相关酶类,使得机体迅速分解代谢酒精,促进肝脏解毒、肾脏排泄的功能,起到醒酒、清脑的作用,石斛则可起到恢复肠胃粘膜和正常菌群,促进消化系统健康,从根本上解决醉酒后机体功能修复的问题。本发明的解酒颗粒剂充分利用了我国传统中医药理论,完全采用大自然药食两用中药,是真正绿色解酒颗粒剂,还具有提高免疫能力、抗脂质过氧化、抗肿瘤、抗衰老等生物功能。
具体实施方式
实施例1
以金花茶-石斛为原料的解酒颗粒剂的有效成分的重量份数为:金花茶叶15份、葛根叶40份、金盏花17份、铁皮石斛纳米粉3份、白茅根10份,菊花15份。
其生产方法的工艺步骤如下:
将金花茶叶、葛根叶、金盏花、白茅根和菊花按重量份比配好后,送入粉碎机粉碎,送入粉碎机粉碎,搅拌均匀,加入其重量8倍的水,煎煮两次后过滤,将滤液浓缩成稠膏(60℃时相对密度1.2)加入适量辅料8份,辅料包括菊粉4份、低聚果糖3份和低聚木糖1份,铁皮石斛纳米粉3份,快速搅拌干燥制粒,按每包4包装、检验、装袋、装箱,颗粒剂制成。
实施例2
以金花茶-石斛为原料的解酒颗粒剂由以下重量份的原药制成:金花茶花25份、葛根叶20份、金盏花20份、铁皮石斛纳米粉1份、白茅根20份,菊花30份。
其生产方法的工艺步骤如下:
将金花茶花、葛根叶、金盏花、白茅根和菊花按重量份比配好后,送入粉碎机粉碎,,搅拌均匀,加入其重量10倍的水,煎煮两次后过滤,将滤液浓缩成稠膏(60℃时相对密度1.4)加入适量辅料5份,辅料为菊粉2份和低聚麦芽糖3份,铁皮石斛纳米粉1份,快速搅拌干燥制粒,按每包6g包装、检验、装袋、装箱,颗粒剂制成。
实施例3
以金花茶-石斛为原料的解酒颗粒剂由以下重量份的原药制成:金花茶叶20份、葛根花25份、金盏花15份、铁皮石斛纳米粉5份、白茅根17份,菊花20份。
其生产方法的工艺步骤如下:
将金花茶叶、葛根花、金盏花、白茅根和菊花按重量份比配好后,送入粉碎机粉碎,,搅拌均匀,加入其重量9倍的水,煎煮两次后过滤,将滤液浓缩成稠膏(60℃时相对密度1.3)加入适量辅料10份,辅料包括菊粉2份,低聚果糖3份、低聚木糖4份、低聚麦芽糖1份,铁皮石斛纳米粉5份快速搅拌干燥制粒,按每包5g包装、检验、装袋、装箱,颗粒剂制成。
实验例:解酒效果统计资料
临床200例,年龄在18-71岁之间,男166人,女34人,饮酒酒度为37-56°,饮酒量为300-700ml,饮酒2小时后,出现酒精中毒的醉酒症状,其中面色苍白恶心呕吐者32人,面色潮红,意识不清者56人,头痛嗜睡者74人,狂躁不止语无伦次者38人。服用本颗粒剂10g-60g后,在0.5-2小时内,病症完全消除者112人,可有效改善相关症状者62人,无效者26例,(总共人数200)有效率87%,说明本发明可有效解酒护肝。
由此实验结果可知,本发明可有效治疗醉酒引起的头痛、口干、恶心呕吐、意识模糊等症状,见效快,疗程短,治愈率高,并且无毒无副作用。
应用实施例1
谭某,男,29岁,南宁市某保健品销售,与朋友聚会饮53°高粱酒650ml,饮后面色苍白,呕吐,神志不清,同事为其冲服该解酒颗粒剂30g,60分钟后,逐渐清醒,呕吐感消失,次日饮食恢复正常。
应用实施例2
苏某,男,53岁,崇左市某建材公司经理,业务应酬饮酒56°白酒450ml至酒醉,恶心头痛、说话不清,脸红发热,肠胃绞痛,家人将其送至医院,医生采取治疗措施后,家人接回,次日为其服用了该解酒颗粒剂30g,连续服用五日后,肠胃无明显不适,胃口饮食恢复正常。
应用实施例3
李某,女,27岁,南宁市某设计公司职员,因被公司辞退喝闷酒,饮45°白酒300ml至酒醉,脸色涨红、口干、胡言乱语、躁动不安、肠胃不适,家人安抚后,为其冲服该解酒颗粒剂20g,40分钟后情绪恢复稳定,意识逐渐清醒,继续服用10g,休息60分钟后肠胃不适感消失,连续服用2日,胃口逐渐恢复正常,自诉和以往醉酒相比,服用该解酒颗粒剂后,胃口恢复较快。
Claims (1)
1.以金花茶-石斛为原料的解酒颗粒剂,其特征在于,由有效成分和辅料制成,所述有效成分的原料的重量份如下:金花茶叶或茶花15-25份,葛根叶或花20-40份,金盏花15-20份,铁皮石斛纳米粉1-5份,白茅根10-20份,菊花15-30份;
所述的辅料为菊粉和低聚糖类,加入的总重量份数为5-10;所述低聚糖类包括低聚果糖、低聚木糖、低聚麦芽糖的一种或几种;
一种以金花茶-石斛为原料的解酒颗粒剂的生产方法,包括以下工艺步骤:将金花茶或茶花、葛根叶或花、金盏花、白茅根和菊花按重量份比配好后,送入粉碎机粉碎,再加入其重量8-10倍的水,煎煮两次后过滤,将滤液浓缩成60℃时相对密度1 .2-1 .4的稠膏,加入辅料和铁皮石斛纳米粉,快速搅拌干燥制粒,按每包4-6g包装、检验、装袋、装箱,颗粒剂制成。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610456013.9A CN105998797B (zh) | 2016-06-22 | 2016-06-22 | 以金花茶-石斛为原料的解酒颗粒剂及其生产方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610456013.9A CN105998797B (zh) | 2016-06-22 | 2016-06-22 | 以金花茶-石斛为原料的解酒颗粒剂及其生产方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105998797A CN105998797A (zh) | 2016-10-12 |
CN105998797B true CN105998797B (zh) | 2019-12-27 |
Family
ID=57087130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610456013.9A Active CN105998797B (zh) | 2016-06-22 | 2016-06-22 | 以金花茶-石斛为原料的解酒颗粒剂及其生产方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105998797B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112471298A (zh) * | 2020-11-26 | 2021-03-12 | 云南农业大学 | 一种石斛茶及其制备方法和应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102100803A (zh) * | 2009-12-22 | 2011-06-22 | 沈献礼 | 一种具有解酒功能的保健品组合物及其制备方法 |
-
2016
- 2016-06-22 CN CN201610456013.9A patent/CN105998797B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102100803A (zh) * | 2009-12-22 | 2011-06-22 | 沈献礼 | 一种具有解酒功能的保健品组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105998797A (zh) | 2016-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102511869B (zh) | 红枣生姜浓浆 | |
CN103999996A (zh) | 一种保健板栗及其制备方法 | |
CN101700365A (zh) | 一种改善视力的功能性饮料 | |
CN105878812B (zh) | 以金花茶-石斛为原料的解酒饮料及其生产方法 | |
CN101953413A (zh) | 无花果天然养颜减肥冷凉茶及其制备方法 | |
CN107156828A (zh) | 一种适用于炎性肠病患者的全营养配方食品 | |
CN105995712A (zh) | 一种复方滇橄榄粉及其制备方法 | |
CN106858215A (zh) | 一种百香果复合饮料 | |
CN104247913A (zh) | 一种保健米粉 | |
CN102273679A (zh) | 一种饮料的制作方法 | |
CN108813501B (zh) | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 | |
KR20210063657A (ko) | 헛개나무 추출물 및 백년초 분말을 함유한 숙취해소용 천연차 및 그 제조방법 | |
CN105998797B (zh) | 以金花茶-石斛为原料的解酒颗粒剂及其生产方法 | |
CN107047864A (zh) | 慢性咽炎调理保健茶及其制备方法 | |
KR100986210B1 (ko) | 건강보조제 | |
CN104586977A (zh) | 苦丁茶颗粒剂及其生产方法 | |
CN114651968A (zh) | 一种宿醉解酒组合物配方及其制备方法 | |
CN103828985A (zh) | 一种银杏红枣茶 | |
CN102524868A (zh) | 红枣秋梨枇杷浓浆 | |
KR20210041387A (ko) | 갈화 추출물 및 차전자피 분말을 함유한 숙취해소용 천연차 및 그 제조방법 | |
CN108813500B (zh) | 具有补中益气、养血安神和调节人体机能的养生蜂蜜膏 | |
CN102511868A (zh) | 一种添加维生素的红枣阿胶浓浆 | |
CN102524869A (zh) | 红枣秋梨枸杞浓浆 | |
CN102160666A (zh) | 天然有机润肠养颜长寿饮料 | |
CN110679935A (zh) | 一种牛蒡人参精华膏及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231221 Address after: 530007 No. 174, University Road, XiXiangTang District, Nanning City, Guangxi Zhuang Autonomous Region Patentee after: GUANGXI ACADEMY OF AGRICULTURAL SCIENCES Address before: No. 174, Daxue East Road, XiXiangTang District, Nanning City, Guangxi Zhuang Autonomous Region Patentee before: AGRICULTURAL PRODUCTS PROCESSING INSTITUTE, GUANGXI ACADEMY OF AGRICULTURAL SCIENCES |